Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathway
Files in This Item:
|Rowan_et_al_THELANCETRM-D-15-00436_RMS_Upload.pdf||679.12 kB||Adobe PDF||Download|
|Title:||Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathway||Authors:||Rowan, Simon C.
Keane, M. P.
|Permanent link:||http://hdl.handle.net/10197/7557||Date:||Mar-2016||Online since:||2016-08-16T01:00:10Z||Abstract:||Pulmonary hypertension is a well recognised complication of chronic hypoxic lung diseases, which are among the most common causes of death and disability worldwide. Development of pulmonary hypertension independently predicts reduced life expectancy. In chronic obstructive pulmonary disease, long-term oxygen therapy ameliorates pulmonary hypertension and greatly improves survival, although the correction of alveolar hypoxia and pulmonary hypertension is only partial. Advances in understanding of the regulation of vascular smooth muscle tone show that chronic vasoconstriction plays a more important part in the pathogenesis of hypoxic pulmonary hypertension than previously thought, and that structural vascular changes contribute less. Trials of existing vasodilators show that pulmonary hypertension can be ameliorated and systemic oxygen delivery improved in carefully selected patients, although systemic hypotensive effects limit the doses used. Vasoconstrictor pathways that are selective for the pulmonary circulation can be blocked to reduce hypoxic pulmonary hypertension without causing systemic hypotension, and thus provide potential targets for novel therapeutic strategies.||Funding Details:||Health Research Board
Science Foundation Ireland
|Type of material:||Journal Article||Publisher:||Elsevier||Journal:||The Lancet Respiratory Medicine||Volume:||4||Issue:||3||Start page:||225||End page:||236||Copyright (published version):||2016 Elsevier||Keywords:||Pulmonary hypertension; Vasoconstriction; Signalling pathways||DOI:||10.1016/S2213-2600(15)00517-2||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.